A new study shows that hydroxychloroquine (HCQ), the antimalarial drug, combined with azithromycin (AZM), could increase the rate of survival by nearly three times for severely ill COVID-19 patients. The observation study analyzed 255 mechanically ventilated patients at the Saint Barnabas Medical Center in New Jersey.
“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the study, published by medRxiv. says in its conclusion.
By using causal analysis and considering of weight-adjusted cumulative dose, we prove the combined therapy, >3 g HCQ and > 1g AZM greatly increases survival in Covid patients on IMV and that HCQ cumulative dose > 80 mg/kg works substantially better. These data do not yet apply to hospitalized patients not on IMV. Since those with higher doses of HCQ had higher doses of AZM, we cannot solely attribute the causal effect to HCQ/AZM combination therapy. However, it is likely AZM does contribute significantly to this increase in survival rate. Since higher dose HCQ/AZM therapy improves survival by nearly 200% in this population, the safety data are moot.
An analysis of hospitalized COVID patients from last year in New York State’s largest health system found that the death rate of COVID-19 patients on mechanical ventilation was 88 percent, compared to 21 percent overall, when treated with the HCQ/AZM combination.
There have now been over 250 studies into hydroxychloroquine’s effectiveness in treating COVID-19, the overwhelming majority of them showing positive results. Studies on early treatment with the drug showed a 66% improvement in mortality rates. But the media chose to ignore those studies, instead deciding to report on a few heavily flawed studies that allegedly showed the drug was either ineffective or increased mortality.
Dr. Fauci also dismissed the drug’s potential for treating COVID patients, claiming that “valid” scientific data showed hydroxychloroquine wasn’t effective in treating COVID-19.
Last year, as data continued to show that hydroxychloroquine was actually effective in treating COVID-19, doctors who spoke out in support of the drug were censored.
And the human cost of this media assault on hydroxychloroquine was catastrophic. One analysis suggests that over 2.4 million lives worldwide have been unnecessarily lost because hydroxychloroquine was not being widely used as a COVID therapeutic. That’s a lot of people who may have died unnecessarily just because the media hated Trump.